Paydirt
HEPA
Ticker

Hepion Pharmaceuticals, Inc.

HEPA · Healthcare · Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatment for hepatocellular carcinoma (HCC), meta…

Hepion Pharmaceuticals, Inc. (HEPA), in the Healthcare sector, has 5 disclosed filings on Paydirt over the trailing twelve months from 4 corporate insiders: 5 purchases and 0 sales, 5 filed past the deadline. Filers took a median of 9 days from execution to disclosure, and the most recent trade was executed Aug 3 and filed Aug 13. The most active filer was Vincent S LoPriore with 2 filings.

Add to watchlist
Filings, ttm
5
5 buys · 0 sells · 5 late
Traders, ttm
4
4 insiders
Volume, ttmiDollar value disclosed in the window
$1.0M
estimated for Congress, as filed for insiders
Median delay
9d
execution to disclosure
Last traded
Aug 3
Filed Aug 12
ADViAverage daily dollar volume
$1K
market data
Share price · 12M
$0.06 (+9.3%)
$0.09$0.06$0.04Sep 22 2025Mar 4Aug 14

Adjusted for splits and dividends.

Volume by month
$800K$400K$0Oct 2024Apr 2025Oct 2025Apr 2026Apr 2026 · buys $200KAug 2026 · buys $800K
Buys $1.0M Sells $0

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed
VL Vincent S LoPriore Executive Chairman 2 filings SA Sireesh Appajosyula Chief Operating Officer 1 filing MP Michael J. Purcell Director 1 filing GS Gary S. Stetz Interim CEO 1 filing
Recent filings
Gary S. StetzPURCHASE Interim CEO $100K
2,000,000 sh × $0.05
Exec Aug 3
Filed Aug 12 · 9:41 PM ET † Michael J. PurcellPURCHASE Director $100K
2,000,000 sh × $0.05
Exec Aug 3
Filed Aug 12 · 9:39 PM ET † Sireesh AppajosyulaPURCHASE Chief Operating Officer $100K
2,000,000 sh × $0.05
Exec Aug 3
Filed Aug 12 · 9:36 PM ET † Vincent S LoPriorePURCHASE Executive Chairman $500K
10,000,000 sh across 2 lots
Exec Aug 3
Filed Aug 12 · 9:34 PM ET † Vincent S LoPriorePURCHASE Executive Chairman $200K
5,000,000 sh × $0.04
Exec Apr 21
Filed Apr 27 · 6:24 AM ET †